2-piperidone has been researched along with Diabetic Nephropathies in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chirananthavat, T; Claimon, T; Sanpatchayapong, A; Satirapoj, B; Suraamornkul, S; Trakarnvanich, T | 1 |
| Cha, DR; Han, BG; Han, SY; Jang, Y; Jeong, KH; Jo, YI; Kang, SW; Kim, B; Kim, NH; Kim, SG; Na, KR; Oh, KH; Park, HC; Park, SH; Shin, S; Yoon, SA | 1 |
| Choi, YK; Jung, GS; Jung, YA; Lee, IK; Lee, S; Park, KG; Park, M; Seo, JB; Woo, HI | 1 |
| Cho, MH; Ho Kim, S; Jung, E; Kim, J; Kim, S | 1 |
| Cha, DR; Han, BG; Han, SY; Jang, YH; Jeong, KH; Jo, YI; Kang, SW; Kim, NH; Kim, SG; Na, KR; Oh, KH; Park, HC; Park, SH; Shin, SH; Yoon, SA | 1 |
3 trial(s) available for 2-piperidone and Diabetic Nephropathies
| Article | Year |
|---|---|
Effect of Dipeptidyl Peptidase-4 (DPP-4) Inhibition on Biomarkers of Kidney Injury and Vascular Calcification in Diabetic Kidney Disease: A Randomized Controlled Trial.
Topics: Aged; Alkaline Phosphatase; Ankle Brachial Index; Coronary Artery Disease; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dipeptidyl-Peptidase IV Inhibitors; Fatty Acid-Binding Proteins; Female; Glomerular Filtration Rate; Hepatitis A Virus Cellular Receptor 1; Humans; Lipocalin-2; Male; Middle Aged; Osteopontin; Piperidones; Pulse Wave Analysis; Pyrimidines; Reactive Oxygen Species; Vascular Calcification | 2021 |
Comparative efficacy and safety of gemigliptin versus linagliptin in type 2 diabetes patients with renal impairment: A 40-week extension of the GUARD randomized study.
Topics: Aged; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dipeptidyl-Peptidase IV Inhibitors; Double-Blind Method; Drug Monitoring; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin; Kidney; Linagliptin; Male; Middle Aged; Patient Dropouts; Piperidones; Pyrimidines; Renal Insufficiency, Chronic; Severity of Illness Index; Sulfonylurea Compounds | 2018 |
Efficacy, safety and albuminuria-reducing effect of gemigliptin in Korean type 2 diabetes patients with moderate to severe renal impairment: A 12-week, double-blind randomized study (the GUARD Study).
Topics: Aged; Albuminuria; Blood Glucose; Body Weight; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Double-Blind Method; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Male; Middle Aged; Piperidones; Pyrimidines; Republic of Korea; Treatment Outcome | 2017 |
2 other study(ies) available for 2-piperidone and Diabetic Nephropathies
| Article | Year |
|---|---|
Gemigliptin Attenuates Renal Fibrosis Through Down-Regulation of the NLRP3 Inflammasome.
Topics: Administration, Oral; Animals; Cell Line; Diabetic Nephropathies; Dipeptidyl-Peptidase IV Inhibitors; Down-Regulation; Fibrosis; Humans; Inflammasomes; Inflammation; Kidney Tubules, Proximal; Mice; Mice, Inbred C57BL; NLR Family, Pyrin Domain-Containing 3 Protein; Piperidones; Protective Agents; Pyrimidines; Signal Transduction; Transforming Growth Factor beta; Ureteral Obstruction | 2019 |
Gemigliptin improves renal function and attenuates podocyte injury in mice with diabetic nephropathy.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Advanced Oxidation Protein Products; Albuminuria; Animals; Apoptosis; Blood Glucose; Cytoprotection; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Glomerular Filtration Rate; Guanine; Male; Mice, Inbred C57BL; Piperidones; Podocytes; Protein Serine-Threonine Kinases; Pyrimidines; Receptor for Advanced Glycation End Products | 2015 |